Msp Recovery, INC 8-K filings
Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.
OTC.Pink
MSP Recovery, Inc. announced a $0.3 million advance from VRM MSP Recovery Partners, LLC, alongside amendments to its Master Transaction Agreement and Security Agreement.
OTC.Pink
MSP Recovery, Inc. announced its Class A common stock and warrants will move to the OTC Markets Group's Expert Market on July 17, 2026, due to ongoing SEC filing delays.
OTC.Pink
MSP Recovery, Inc. has entered into a letter agreement with Hazel Partners Holdings LLC for a $0.2 million advance to cover operating expenses, with no further committed funding available under the existing credit facility.
OTC.Pink
MSP Recovery, Inc. has entered into a letter agreement with Hazel Partners Holdings LLC for a $0.1 million advance to cover operating expenses, with no further committed funding available.
OTC.Pink
MSP Recovery has entered into new letter agreements to secure approximately $0.22 million in emergency liquidity to address immediate accounts payable obligations.
OTC.Pink
MSP Recovery, Inc. announced two separate funding agreements totaling $0.2 million and a downgrade from the OTCQB Venture Market to the OTC Pink market due to delayed SEC filings.
OTC.Pink
MSP Recovery, Inc. has obtained two separate $0.1 million advances from existing lenders to support immediate operating expenses and accounts payable.
OTC.Pink
MSP Recovery has obtained two separate $0.1 million advances from existing lenders to support immediate operating expenses and accounts payable.
OTC.Pink
MSP Recovery, Inc. received a one-time $250,000 advance from Hazel Partners Holdings LLC for operating expenses, with no commitment for future funding.
OTC.Pink
MSP Recovery, Inc. received a $300,000 discretionary advance from Hazel Partners Holdings LLC for operating expenses, but warns of no further committed liquidity.
OTC.Pink
MSP Recovery, Inc. received a crucial extension from Yorkville on a technical default triggered by its Nasdaq delisting, deferring immediate acceleration of $3.6 million in convertible notes.
OTC.Pink
MSP Recovery, Inc. secured a one-time $325,000 advance from Hazel Partners Holdings LLC for operating expenses, with no commitment for future funding.
OTC.Pink
MSP Recovery, Inc. announced its Class A common stock was delisted from Nasdaq, its warrants transferred to the OTCID Basic Market, and 33% of its workforce was furloughed.
OTC.Pink
MSP Recovery, Inc. announced the departure of Chief Operating Officer Ricardo Rivera, effective December 22, 2025, with no disagreement cited.
OTC.Pink
MSP Recovery, Inc. announced its common stock will be delisted from the Nasdaq Capital Market effective December 22, 2025, due to non-compliance with minimum stockholders' equity and bid price rules.
OTC.Pink
MSP Recovery, Inc. announced the conclusion of the SEC's investigation into the company and its officers without any recommendation for enforcement action.
OTC.Pink
MSP Recovery, Inc. received additional delisting notices from Nasdaq due to non-compliance with minimum stockholders' equity and bid price requirements, with a hearing scheduled for December 11, 2025.
OTC.Pink
MSP Recovery, Inc. received a Nasdaq delisting notice, while simultaneously amending a $35.4 million promissory note with Nomura and securing a $0.5 million convertible note advance from Yorkville with a reduced floor price.
OTC.Pink
MSP Recovery, Inc. entered into a second supplemental agreement with Yorkville for up to $3.0 million in additional convertible note funding and announced the resignation of its General Counsel.
OTC.Pink
MSP Recovery, Inc. has agreed with Yorkville to reduce the Floor Price under their Standby Equity Purchase Agreement from $1.60 to $1.20 per share, effective September 29, 2025.
OTC.Pink
MSP Recovery, Inc. announced confidential settlement agreements totaling $2.9 million in cash, including deals with a property and casualty insurer and a pharmaceutical manufacturer.
OTC.Pink
MSP Recovery, Inc. announced an agreement with Yorkville to reduce the Floor Price under their Standby Equity Purchase Agreement from $2.00 to $1.60 per share.
OTC.Pink
MSP Recovery, Inc. announced the full and final settlement of its litigation with Cano Health, LLC, resolving all disputes without admission of liability.
OTC.Pink
MSP Recovery, Inc. announced an agreement with Yorkville to reduce the Floor Price under their Standby Equity Purchase Agreement from $3.50 to $2.00 per share.
OTC.Pink
MSP Recovery, Inc. completed a 1-for-7 reverse stock split to maintain Nasdaq listing compliance, effective September 1, 2025.
OTC.Pink
MSP Recovery, Inc. has entered into a non-binding term sheet for a potential $55.0 million secured delayed draw term loan facility, including significant warrant issuance to the lender.
OTC.Pink
A jury found MSP Recovery, Inc.'s subsidiary, MSP Recovery, LLC, liable for breach of an oral contract, awarding plaintiffs approximately $12.7 million in damages.
OTC.Pink
MSP Recovery, Inc. stockholders approved a reverse stock split and the issuance of Class A Common Stock upon warrant exercise to ensure Nasdaq compliance.
OTC.Pink
MSP Recovery, Inc. secured an additional $0.75 million in convertible note funding from Yorkville and re-elected its Class III directors at the 2025 Annual Meeting.
OTC.Pink
MSP Recovery, Inc. and Yorkville Advisors Global, LP agreed to reduce the Floor Price under their Standby Equity Purchase Agreement from $1.00 to $0.50 per share.